NTRA News and Press, Natera Inc.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its second quarter ended June 30, 2024, after the market close on Aug. 8, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET...

Study reports high accuracy of Signatera for surveillance of MCC patients, suggests potential to reduce frequency of surveillance imaging Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in the Journal of Clinical Oncolog...

2024-07-26 05:15:00 ET Summary With inflation slowing in many countries, equity markets saw modest returns in Q2. Stocks in emerging markets and North America performed particularly well. The portfolio came up short against its benchmark, the MSCI AC World Index, this quarter. ...

2024-07-23 12:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-07-23 10:00:00 ET Summary Market performance was mixed during the quarter as investors navigated macro uncertainties. U.S. large cap growth was up while international, small caps and value lagged. The rally in U.S. growth was dominated by semiconductors, technology hardware and m...

2024-07-19 06:50:00 ET Summary Parnassus Growth Equity Fund (Investor Shares) returned 3.74% (net of fees) for the quarter, underperforming the Russell 1000 Growth Index’s 8.33%. The underperformance was primarily driven by our stock selection in the Information Technology ...

2024-07-15 13:01:09 ET Summary Today, we circle back to diagnostic testing concern CareDx, Inc for the first time in 2024. The stock has moved up some 60% since the company delivered better than expected quarterly results in early May. The company has appointed a new CEO and s...

2024-07-13 10:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-07-12 14:30:06 ET More on Exact Sciences: Exact Sciences: Still No Reason To Own Exact Sciences Corporation (EXAS) Q1 2024 Earnings Call Transcript Exact Sciences initiated at sector outperform at Scotiabank on advanced diagnostics Exact Sciences gains a...

2024-07-12 11:24:12 ET More on etc. Riskified: Strong Value Proposition, Large TAM; Multiple Expansion Likely Downgrade Alert: AMD's Uphill Battle Against Nvidia Is Getting Much Steeper Redwire: Capitalizing On The Space Economy Hollysys Automation ticks high...